Belviq® and Belviq XR® Linked To Cancer
Home »
Did you or a loved one take Belviq® or Belviq XR® for weight-loss? You may be at risk for cancer including pancreatic, colorectal and lung cancer.
Belviq® and Belviq XR® Weight-Loss Drug Recalled
The U.S. Food and Drug Administration (FDA) announced that Japanese drug maker, Eisai Inc. has agreed to voluntarily withdraw its weight-loss drugs Belviq® (lorcaserin) and long-acting form, Belviq XR® after studies showed an increased risk of cancer in patients.
The FDA requested the withdrawal based on a five (5) year study involving 12,000 patients. The study showed that patients taking Belviq® were diagnosed with cancer at a higher rate than patients taking a placebo.
The FDA has recommended that patients should stop taking Belviq® and should talk to their doctor about options for alternative weight-loss medications. The FDA isn’t recommending that patients get extra screening at this point.
Belviq® Cancer Study
On February 13, 2020, the FDA declared that the drug maker has arranged to withdraw Belviq® from the U.S. market.
In 2012, Belviq® (lorcaserin) was approved for weight-loss. The manufacturer is Japanese drug company Eisai, Inc., was required to conduct long-term safety studies into cardiac safety. The FDA’s review of the study in January of 2020 showed no hear risk, but revealed the increased risk of cancer.
The results of the five-year study showed an increase in the overall cancer rate for the Belviq® group compared to the placebo group with comprehensive use. Pancreatic cancer, colorectal cancer, and lung cancer were particularly present in Belviq® users.
If you or a loved one took Belviq® or Belviq XR® and were diagnosed with cancer, fill out the form on this page or call the Olinde Firm right now for a free consultation. You may be eligible for compensation for the harm caused and should seek legal advice.
FREE CASE REVIEW
Contact Our Attorneys for a Free Consultation.
Our lawyers have represented thousands against big pharmaceutical companies. If you or a loved one have been diagnosed with cancer after taking Belviq® or Belviq XR®, call 1-800-587-1889 today for a free, no-obligation lawsuit evaluation.
New Orleans
Of Counsel at Huber, Thomas & Marcelle
1100 Poydras Street, Suite 2200
New Orleans, LA 70163
Phone: (504) 587-1440
Toll Free:1-800-587-1889
North Shore
Mailing Address
P.O. Box 55
Mandeville, LA 70470
Phone: (504) 587-1440
Toll Free: 1-800-587-1889
New Orleans East
New Orleans East Office
8816 Chef Menteur Highway
Suite B
New Orleans, LA 70127
Phone: (504) 587-1440
Toll Free: 1-800-587-1889
Free Case Evaluation
Copyright © 2020 The Olinde Firm - New Orleans Attorneys. All rights reserved. Disclaimer The information contained in this website may be considered advertising under the Rules of the Supreme Judicial Court of Louisiana and is for general information purposes only. Nothing contained within this or associated pages, documents, emails, or other communications should be taken as legal advice for any individual case or situation. The information on this website is not intended to create, and communications exchanged in connection with this website are not intended to create or constitute an attorney-client relationship. Although all communications are considered confidential, we do not accept representation of clients until such time as we enter into a written agreement for such representation.